London, UK
+919405476170
+919405476170

Lapalieva 250mg (Generic Tykerb) UK | Wholesale Oncology Supply | Ernest Oncology

Global Exporter & Bulk Supplier: Lapalieva 250mg Tablet 

๐ŸŒ International Market Supply Overview

Are you looking to optimize your pharmaceutical supply pipeline with an accredited, high-capacity international source for targeted oncology therapeutics? Ernest Oncology (the specialized oncology division of the Group of Ernest Pharmaceutical Pvt. Ltd.) is a top-tier global supplier, bulk exporter, and distributor of Lapalieva 250mg Tablets.

Utilizing an established global medical logistics network, we manage secure bulk export channels to distribute Lapatinib 250mg directly to hospital networks, government health ministries, regional oncology dispensaries, and pharmaceutical importers across the USA, UK, Australia, and South Africa.


๐Ÿ”ฌ Clinical Profile & Product Specifications

Lapalieva 250mg contains Lapatinib, a potent, reversible, and selective dual tyrosine kinase inhibitor (TKI). It is engineered as a targeted anti-cancer agent designed to disrupt the cellular pathways responsible for aggressive tumor proliferation.

  • Active Pharmaceutical Ingredient: Lapatinib (250mg)

  • Therapeutic Classification: Antineoplastic Agent / Dual Tyrosine Kinase Inhibitor (TKI)

  • Mechanism of Action: Lapalieva 250mg exerts an advanced dual-blockade intracellular mechanism. It binds directly to the intracellular kinase domains of both Epidermal Growth Factor Receptor (EGFR / ErbB1) and Human Epidermal Growth Factor Receptor 2 (HER2 / ErbB2). By inhibiting the autophosphorylation of these receptors, Lapatinib effectively shuts down the downstream MAPK and PI3K/Akt signaling cascades. This intracellular blockade arrests cell cycle progression, limits angiogenesis, and triggers apoptosis (programmed cell death) in tumor cells overexpressing these specific receptor lines.

  • Primary Clinical Indications:

    • HER2-Positive Advanced or Metastatic Breast Cancer: Frequently deployed in combination with Capecitabine for patients whose tumors overexpress HER2 and who have shown disease progression following prior standard therapies (including anthracyclines, taxanes, and trastuzumab).

    • Hormone Receptor-Positive Metastatic Breast Cancer: Administered in combination with an aromatase inhibitor (such as Letrozole) for postmenopausal women presenting with hormone receptor-positive, HER2-overexpressing metastatic disease, for whom endocrine therapy is indicated.

  • Administration Protocol: Tablets must be administered orally on an empty stomachโ€”strictly at least 1 hour before or 2 hours following a meal. The tablets must be swallowed whole with water and should never be broken, crushed, split, or chewed.

๐Ÿ“ฆ Wholesale B2B Sourcing & Logistics Capabilities

  • Validated Quality Assurance: Sourced directly from cutting-edge manufacturing lines operating under strict Good Manufacturing Practice (GMP) compliance, guaranteeing optimal purity, structural stability, and absolute batch uniformity.

  • Cold-Chain & Regulatory Logistics: Comprehensive customs management tailored to navigate complex import-export regulations, customs clearances, and medical shipping compliance in the USA, UK, Australia, and South Africa.

  • Institutional Supply Scale: Well-equipped to service large-scale wholesale contracts, specialized oncology clinical tenders, and public/private health-system procurement networks.

  • Comprehensive B2B Documentation: Every shipment is backed by verified regulatory compliance documentation, including full batches of Certificates of Analysis (COA), tracing profiles, and international safety documentation.

PRESCRIPTION MEDICINE IS: YES

โš ๏ธDisclaimer

Lapalieva 250mg Tablet is a highly potent prescription antineoplastic medication. It must strictly be administered under the direct prescription, supervision, and ongoing laboratory monitoring of a certified clinical oncologist. This profile is intended exclusively for international B2B trade, health system procurement officers, and licensed bulk distribution channels; it does not replace or constitute professional medical advice.


๐Ÿ“ž Contact Ernest Oncology โ€” Global Medicine Exporter

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]


๐ŸŒ Websites:

๐Ÿ“ง Email: exports@ernestpharmaceuticals.com

๐Ÿ“ฆ Business Type: Exporter | Bulk Supplier | Distributor

๐Ÿ“ฒ WhatsApp: +91 93599 02383

๐Ÿ”— WhatsApp Direct Link:https://wa.me/919359902383

 2026-05-20T08:30:45

Keywords